ENDOLOGIX INC's ticker is ELGX and the CUSIP is 29266S106. A total of 107 filers reported holding ENDOLOGIX INC in Q2 2018. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $6,147,000 | -7.7% | 930,001 | -90.0% | 0.31% | -3.2% |
| Q4 2018 | $6,659,000 | -62.5% | 9,300,000 | 0.0% | 0.32% | -58.4% |
| Q3 2018 | $17,763,000 | -66.3% | 9,300,000 | 0.0% | 0.76% | -62.5% |
| Q2 2018 | $52,638,000 | +33.8% | 9,300,000 | 0.0% | 2.02% | +4.9% |
| Q1 2018 | $39,339,000 | -8.1% | 9,300,000 | +16.2% | 1.93% | -7.8% |
| Q4 2017 | $42,800,000 | +20.0% | 8,000,000 | 0.0% | 2.10% | -7.3% |
| Q3 2017 | $35,680,000 | -2.1% | 8,000,000 | +6.7% | 2.26% | +27.4% |
| Q2 2017 | $36,450,000 | -16.1% | 7,500,000 | +25.0% | 1.78% | +0.7% |
| Q1 2017 | $43,440,000 | +108.9% | 6,000,000 | +65.1% | 1.76% | +62.7% |
| Q4 2016 | $20,792,000 | +62.4% | 3,635,000 | +263.5% | 1.08% | +92.4% |
| Q3 2016 | $12,800,000 | -65.8% | 1,000,000 | -66.7% | 0.56% | -68.8% |
| Q2 2016 | $37,380,000 | +15.7% | 3,000,000 | -22.4% | 1.81% | -4.5% |
| Q1 2016 | $32,307,000 | – | 3,864,500 | – | 1.89% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Capital Management, LLC | 4,050,000 | $49,653,000 | 5.91% |
| Essex Woodlands Management, Inc. | 1,257,468 | $21,220,000 | 3.88% |
| PURA VIDA INVESTMENTS, LLC | 205,100 | $2,515,000 | 1.44% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,347,113 | $28,776,000 | 1.11% |
| First Light Asset Management, LLC | 180,963 | $2,219,000 | 1.10% |
| ArrowMark Colorado Holdings LLC | 2,889,546 | $35,426,000 | 0.97% |
| PALISADE CAPITAL MANAGEMENT, LP | 2,149,949 | $26,358,000 | 0.78% |
| Iguana Healthcare Management, LLC | 150,000 | $1,839,000 | 0.72% |
| CADIAN CAPITAL MANAGEMENT, LP | 1,492,443 | $18,297,000 | 0.66% |
| WASHINGTON CAPITAL MANAGEMENT, INC | 85,882 | $1,053,000 | 0.66% |